Recruiting
Phase 2

HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy

Sponsor:

Children's Hospital Medical Center, Cincinnati

Code:

NCT02143830

Conditions

Fanconi Anemia

Severe Marrow Failure

Myelodysplastic Syndrome (MDS)

Acute Myelogenous Leukemia (AML)

Eligibility Criteria

Sex: All

Age: 3+

Healthy Volunteers: Not accepted

Interventions

Busulfan

Cyclophosphamide

Fludarabine

rabbit ATG

G-CSF

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information